Terns Pharmaceuticals (TERN) had the highest return between October 28, 2025 and November 30, 2025 by a mid-cap US stock, returning 250.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Terns Pharmaceuticals (TERN) | 10/28/2025 - 11/30/2025 | 250.06% |
Olema Pharmaceuticals (OLMA) | 10/28/2025 - 11/30/2025 | 223.66% |
PACS (PACS) | 10/28/2025 - 11/30/2025 | 164.74% |
Cogent Biosciences (COGT) | 10/28/2025 - 11/30/2025 | 147.51% |
Cidara Therapeutics (CDTX) | 10/28/2025 - 11/30/2025 | 119.86% |
Edgewise Therapeutics (EWTX) | 10/28/2025 - 11/30/2025 | 62.45% |
Inspire Medical Systems (INSP) | 10/28/2025 - 11/30/2025 | 59.89% |
Haemonetics (HAE) | 10/28/2025 - 11/30/2025 | 59.54% |
Nuvation Bio (NUVB) | 10/28/2025 - 11/30/2025 | 59.33% |
Aris Mining (ARMN) | 10/28/2025 - 11/30/2025 | 58.64% |
Comstock Resources (CRK) | 10/28/2025 - 11/30/2025 | 54.72% |
Kohl's (KSS) | 10/28/2025 - 11/30/2025 | 52.26% |
Belite Bio Inc ADR (BLTE) | 10/28/2025 - 11/30/2025 | 46.99% |
Scholar Rock (SRRK) | 10/28/2025 - 11/30/2025 | 46.87% |
Zymeworks Inc Common Stock (ZYME) | 10/28/2025 - 11/30/2025 | 43.22% |
Globalstar, Inc Common Stock (GSAT) | 10/28/2025 - 11/30/2025 | 42.71% |
Liquidia Technologies (LQDA) | 10/28/2025 - 11/30/2025 | 42.68% |
Glaukos (GKOS) | 10/28/2025 - 11/30/2025 | 41.72% |
Polibeli Group Ltd Class A Ordinary Shares (PLBL) | 10/28/2025 - 11/30/2025 | 40.96% |
Seaboard (SEB) | 10/28/2025 - 11/30/2025 | 40.36% |
Orla Mining (ORLA) | 10/28/2025 - 11/30/2025 | 40.16% |
Arcus Biosciences (RCUS) | 10/28/2025 - 11/30/2025 | 39.87% |
McGraw Hill (MH) | 10/28/2025 - 11/30/2025 | 39.73% |
Viridian Therapeutics (VRDN) | 10/28/2025 - 11/30/2025 | 39.69% |
Brighthouse Financial (BHF) | 10/28/2025 - 11/30/2025 | 39.68% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
